Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study

被引：0

作者：

Cristina Pellegrini

Maria Esposito

Ernesto Rossi

Paolo Gisondi

Stefano Piaserico

Paolo Dapavo

Andrea Conti

Alessio Gambardella

Martina Burlando

Alessandra Narcisi

Annamaria Offidani

Riccardo Balestri

Federico Bardazzi

Francesca Prignano

Cristina Mugheddu

Marco Romanelli

Giovanna Malara

Giovanni Schinzari

Maria Concetta Fargnoli

机构：

[1] University of L’Aquila,Dermatology, Department of Applied Clinical and Biotechnological Sciences

[2] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Medical Oncology

[3] University of Verona,Section of Dermatology and Venereology, Department of Medicine

[4] University of Padova,Dermatology Unit, Department of Medicine

[5] S.C. Dermatologia U,Dermatologic Unit, Department of General Surgery

[6] AOU Città della Salute e della Scienza di Torino,Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine

[7] Infermi Hospital,Department of Dermatology

[8] AUSL Romagna,Dermatology

[9] University of Campania Luigi Vanvitelli,Department of Biomedical Sciences

[10] Dipartimento di scienze della salute - DISSAL Ospedale Policlinico San Martino,Department of Clinical and Molecular Sciences, Dermatology Unit

[11] University of Genoa,Division of Dermatology

[12] Humanitas Clinical and Research Center-IRCCS,Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine Alma Mater Studiorum

[13] Humanitas University,Department of Health Science, Dermatology Unit

[14] Polytechnic Marche,Section of Dermatology, Department of Medical Sciences and Public Health

[15] University,Department of Dermatology

[16] Hospital of Trento,Dermatology Department

[17] IRCCS Azienda Ospedaliero Universitaria Bologna,Medical Oncology

[18] University of Bologna,undefined

[19] University of Florence,undefined

[20] University of Cagliari,undefined

[21] University of Pisa,undefined

[22] Grande Ospedale Metropolitano “BMM” Reggio Calabria,undefined

[23] Università Cattolica del S. Cuore,undefined

来源：

Dermatology and Therapy | 2022年 / 12卷

关键词：

Secukinumab; Psoriasis; Cancer; Biologics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2613 / 2626

页数：13

共 153 条

[1]

Boehncke WH(2015)The risk of cancer in patients with psoriasis: a population-based cohort study in the Health Improvement Network Psoriasis Lancet 386 983-994

[2]

Schon MP(2016)Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies JAMA Dermatol 152 282-290

[3]

Chiesa Fuxench ZC(2013)Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis J Eur Acad Dermatol Venereol 27 336-346

[4]

Shin DB(2020)Immunotherapies in cutaneous pathologies: an overview JAMA Dermatol 156 421-429

[5]

Ogdie Beatty A(2021)IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis Drug Discov Today 26 248-255

[6]

Gelfand JM(2019)Secukinumab in plaque psoriasis–results of two phase 3 trials J Allergy Clin Immunol 144 750-763

[7]

Pouplard C(2014)Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data N Engl J Med 371 326-338

[8]

Brenaut E(2019)Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study Arthritis Res Ther 21 111-2003

[9]

Horreau C(2017)Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease Rheumatology (Oxford) 56 1993-1173

[10]

Barnetche T(2020)Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial J Eur Acad Dermatol Venereol 34 1161-409

← 1 2 3 4 5 6 7 8 9 10 →